Table 1.
Considerations in Resuming Elective Endoscopy
| Total (n = 122) | ASC (n = 67) | Hospital-based (n = 55) | P value | |
|---|---|---|---|---|
| Please select the 3 most important factors that influenced/will influence your decision to resume elective endoscopic procedures? | ||||
| Availability of COVID-19 testing | 84 (68.9%) | 38 (56.7%) | 46 (83.6%) | .001 |
| Community prevalence of COVID-19 | 97 (79.5%) | 53 (79.1%) | 44 (80%) | .9 |
| Patients advocating for resumption of endoscopy | 35 (28.7%) | 21 (31.3%) | 14 (25.5%) | .47 |
| Institutional financial considerations | 29 (23.8%) | 13 (19.4%) | 16 (29.1%) | .21 |
| Physician financial considerations | 17 (13.9%) | 10 (14.9%) | 7 (12.7%) | .7 |
| PPE availability | 91 (74.6%) | 52 (77.6%) | 39 (70.1%) | .39 |
| What do you see as barriers to increasing endoscopic procedure volume once cleared to restart operations by institution/local government? (check all that apply) | ||||
| Inadequate PPE availability | 66 (54%) | 34 (50.7%) | 32 (58.2%) | .4 |
| Limited COVID-19 testing capacity | 85 (69%) | 43 (64.2%) | 42 (76.4%) | .15 |
| Inadequate nursing/support staff | 18 (14.6%) | 5 (7.5%) | 13 (23.6%) | .012 |
| Financial constraints | 12 (9.8%) | 7 (10.4%) | 5 (9.1%) | .8 |
| Patient safety concerns | 80 (65.9%) | 43 (64.2%) | 37 (67.3%) | .72 |
| Staff safety concerns | 45 (36.6%) | 24 (35.8%) | 21 (38.2%) | .79 |
| Limited anesthesia coverage | 13 (10.6%) | 4 (6%) | 9 (16.4%) | .064 |
ASC, ambulatory surgery center; PPE, personal protective equipment.